Logo image of NDLS

NOODLES & CO (NDLS) Stock Fundamental Analysis

NASDAQ:NDLS - Nasdaq - US65540B1052 - Common Stock - Currency: USD

1.02  -0.08 (-7.27%)

Premarket: 0.7999 -0.22 (-21.58%)

Fundamental Rating

1

Overall NDLS gets a fundamental rating of 1 out of 10. We evaluated NDLS against 131 industry peers in the Hotels, Restaurants & Leisure industry. NDLS has a bad profitability rating. Also its financial health evaluation is rather negative. NDLS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NDLS had negative earnings in the past year.
In the past year NDLS had a positive cash flow from operations.
In the past 5 years NDLS reported 4 times negative net income.
Each year in the past 5 years NDLS had a positive operating cash flow.
NDLS Yearly Net Income VS EBIT VS OCF VS FCFNDLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

The Return On Assets of NDLS (-12.25%) is worse than 87.02% of its industry peers.
Industry RankSector Rank
ROA -12.25%
ROE N/A
ROIC N/A
ROA(3y)-4.93%
ROA(5y)-4.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NDLS Yearly ROA, ROE, ROICNDLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

Looking at the Gross Margin, with a value of 23.59%, NDLS is doing worse than 81.68% of the companies in the same industry.
In the last couple of years the Gross Margin of NDLS has declined.
The Profit Margin and Operating Margin are not available for NDLS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.5%
NDLS Yearly Profit, Operating, Gross MarginsNDLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

0

2. Health

2.1 Basic Checks

NDLS does not have a ROIC to compare to the WACC, probably because it is not profitable.
NDLS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NDLS has more shares outstanding
Compared to 1 year ago, NDLS has a worse debt to assets ratio.
NDLS Yearly Shares OutstandingNDLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NDLS Yearly Total Debt VS Total AssetsNDLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 0.50, we must say that NDLS is in the distress zone and has some risk of bankruptcy.
NDLS has a Altman-Z score of 0.50. This is in the lower half of the industry: NDLS underperforms 77.86% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.5
ROIC/WACCN/A
WACC9.46%
NDLS Yearly LT Debt VS Equity VS FCFNDLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

NDLS has a Current Ratio of 0.29. This is a bad value and indicates that NDLS is not financially healthy enough and could expect problems in meeting its short term obligations.
NDLS has a worse Current ratio (0.29) than 88.55% of its industry peers.
A Quick Ratio of 0.13 indicates that NDLS may have some problems paying its short term obligations.
NDLS has a worse Quick ratio (0.13) than 97.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.13
NDLS Yearly Current Assets VS Current LiabilitesNDLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

NDLS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -188.89%.
NDLS shows a decrease in Revenue. In the last year, the revenue decreased by -0.63%.
Measured over the past years, NDLS shows a small growth in Revenue. The Revenue has been growing by 1.30% on average per year.
EPS 1Y (TTM)-188.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
Revenue 1Y (TTM)-0.63%
Revenue growth 3Y1.25%
Revenue growth 5Y1.3%
Sales Q2Q%1.98%

3.2 Future

NDLS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.99% yearly.
NDLS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.81% yearly.
EPS Next Y17.27%
EPS Next 2Y22.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.95%
Revenue Next 2Y1.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NDLS Yearly Revenue VS EstimatesNDLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
NDLS Yearly EPS VS EstimatesNDLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NDLS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NDLS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NDLS Price Earnings VS Forward Price EarningsNDLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NDLS indicates a rather cheap valuation: NDLS is cheaper than 80.92% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.09
NDLS Per share dataNDLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

NDLS's earnings are expected to grow with 22.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.99%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NDLS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NOODLES & CO

NASDAQ:NDLS (8/13/2025, 8:26:38 PM)

Premarket: 0.7999 -0.22 (-21.58%)

1.02

-0.08 (-7.27%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-04 2025-11-04
Inst Owners36.8%
Inst Owner Change-1.78%
Ins Owners6%
Ins Owner Change5.18%
Market Cap46.86M
Analysts84.44
Price Target2.89 (183.33%)
Short Float %2.02%
Short Ratio3.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.66%
Min EPS beat(2)-96.08%
Max EPS beat(2)-19.24%
EPS beat(4)1
Avg EPS beat(4)-53.71%
Min EPS beat(4)-107.6%
Max EPS beat(4)8.08%
EPS beat(8)3
Avg EPS beat(8)-52.27%
EPS beat(12)5
Avg EPS beat(12)-34.18%
EPS beat(16)7
Avg EPS beat(16)-32.77%
Revenue beat(2)0
Avg Revenue beat(2)-1.87%
Min Revenue beat(2)-2.15%
Max Revenue beat(2)-1.59%
Revenue beat(4)0
Avg Revenue beat(4)-3.15%
Min Revenue beat(4)-4.47%
Max Revenue beat(4)-1.59%
Revenue beat(8)0
Avg Revenue beat(8)-3.5%
Revenue beat(12)0
Avg Revenue beat(12)-2.81%
Revenue beat(16)0
Avg Revenue beat(16)-2.8%
PT rev (1m)0%
PT rev (3m)-1.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-37.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-15.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF 10.21
P/B N/A
P/tB N/A
EV/EBITDA 8.09
EPS(TTM)-0.52
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)0.1
OCFY9.79%
SpS10.79
BVpS-0.3
TBVpS-0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.25%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.59%
FCFM N/A
ROA(3y)-4.93%
ROA(5y)-4.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.5%
F-Score3
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 5.61
Cap/Depr 80.03%
Cap/Sales 4.65%
Interest Coverage N/A
Cash Conversion 24.09%
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.13
Altman-Z 0.5
F-Score3
WACC9.46%
ROIC/WACCN/A
Cap/Depr(3y)146.29%
Cap/Depr(5y)115.44%
Cap/Sales(3y)7.61%
Cap/Sales(5y)5.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-188.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
EPS Next Y17.27%
EPS Next 2Y22.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.63%
Revenue growth 3Y1.25%
Revenue growth 5Y1.3%
Sales Q2Q%1.98%
Revenue Next Year2.95%
Revenue Next 2Y1.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1015.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year375.41%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.91%
OCF growth 3Y-40.65%
OCF growth 5Y-24.12%